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A B S T R A C T   
Objectives: To assess systemic, environmental and lifestyle risk factors for dry eye disease (DED) in a Mediter-
ranean Caucasian population. 
Methods: A cross-sectional study was performed on 120 Caucasian participants aged between 18 and 89 years 
(47.0 ± 22.8 years). Medical history, information regarding environmental conditions and lifestyle, Ocular 
Surface Disease Index, Dry Eye Questionnaire-5, non-Invasive (Oculus Keratograph 5 M) breakup time, tear film 
osmolarity and ocular surface staining parameters were assessed in a single clinical session to allow DED 
diagnosis based on the guidelines of the Tear Film and Ocular Surface Society Dry Eye Workshop II Diagnostic 
Methodology Report. A multivariate logistic regression model was constructed including those variables with a p- 
value less than 0.15 in the univariate analysis. 
Results: A prevalence of 57.7 % for DED was found. No age differences were found between those with and 
without DED (U = 1886.5, p = 0.243). Nevertheless, the DED group had more females (X2 = 7.033, p = 0.008). 
The univariate logistic regression identified as potential risk factors for DED the following: female sex, sleep 
hours per day, menopause, anxiety, systemic rheumatologic disease, use of anxiolytics, daily medication, ocular 
surgery, poor diet quality, more ultra-processed food in diet, not drinking caffeine and hours of exposure to air 
conditioning per day. Multivariate logistic regression revealed that hours of sleep per day, menopause and use of 
anxiolytics were independently associated with DED (p ≤ 0.026 for all). 
Conclusions: DED is associated with systemic, environmental and lifestyle risk factors. These findings are useful to 
identify potentially modifiable risk factors, in addition to conventional treatments for DED.   
1. Introduction 
According to the Tear Film and Ocular Surface Society Dry Eye 
Workshop II (TFOS DEWS II), dry eye disease (DED) is defined as a 
multifactorial disease characterized by the loss of tear film homeostasis, 
which is accompanied by symptoms of ocular dryness [1]. The preva-
lence of DED is increasing substantially worldwide influenced by de-
mographic, systemic and environmental factors. DED prevalence ranges 
from 5 to 50 % at various ages [2,3], impacting quality of life, visual 
function, ocular healthiness and work productivity of those who suffer 
from it [1,2]. Moreover, the multifactorial and heterogeneous aetiology 
of the disease indicated the tear film and the ocular surface integrity are 
highly influenced by a wide range of risk factors [2]. 
The TFOS DEWS II Epidemiology Report listed several risk factors for 
DED [2]. This meta-analysis showed that the prevalence of DED in-
creases with age, female sex and Asian ethnicity. Nevertheless, very few 
of the studies included in the analysis incorporated young people. Also, 
the report highlighted that some of the listed risk factors are still 
inconclusive and there is not yet clear evidence that most of them induce 
DED [2]. Moreover, studies have significant differences in the method-
ology and in the procedure followed to diagnose DED, which makes their 
direct comparison and the building of global conclusions particularly 
challenging [2,4–6]. In the report, the authors argued that there is still a 
considerable lack of information about risk factors for DED and that the 
implementation of studies to assess such factors in different geographic 
regions is required. 
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To the authors’ knowledge, there are only two studies [4,6] that have 
evaluated DED risk factors following the TFOS DEWS II guidelines for 
the diagnosis and identification of potential risk factors for DED, both 
performed on a cohort in New Zealand. Authors found that age, 
ethnicity, migraine, systemic rheumatologic disease, thyroid disease, 
use of antidepressant medication, oral contraceptive therapy, increased 
digital screen exposure time and reduced caffeine consumption were 
independently associated with DED [4,6]. Authors [4,6] also acknowl-
edged the need to analyse non-significant potential risk factors that were 
not very prevalent in their population. Furthermore, these studies did 
not consider interactions between demographic, systemic and lifestyle 
risk factors, since systematic risk factors were assessed separately from 
lifestyle factors [4,6]. 
This study is the first to examine DED in a Mediterranean Caucasian 
population using the standardised TFOS DEWS II criteria and analyzes 
systemic, environmental and lifestyle DED risk factors [2,5]. In addition, 
new lifestyle and environmental risk factors have been included in the 
analysis. 
2. Material and methods 
One hundred and twenty Caucasian volunteers ranging in age from 
18 to 89 years (47.0 ± 22.8 years) participated in this cross-sectional 
study. In order to evaluate different health and tear film status, no 
exclusion based on health or tear film parameters was made. Contact 
lens users were instructed not to wear their contact lenses for the 48 h 
prior to examination [4,6]. Participants with ocular surgery within the 
previous three months were excluded. Only volunteers who lived in the 
region were enroled to minimize environmental differences [4,6]. Only 
the right eye of each participant was assessed to avoid data bias (except 
for tear osmolarity which was measured from each eye as recom-
mended). The study was carried out in accordance with the tenets of the 
Declaration of Helsinki and was approved by the Ethics Committee of 
the University of Valencia. Written consent from each participant was 
obtained after a verbal explanation of the protocol, nature and possible 
consequences of the study. Recruitment was carried out by advertise-
ment within University dissemination channels, campus personnel and 
students, as well as in local public entities in nearby towns. 
2.1. Measurements 
Ocular surface was assessed using the Oculus Keratograph 5 M (K5 
M; Oculus GmbH, Wetzlar, Germany) and the TearLab Osmolarity de-
vice (TearLab Corporation, San Diego, CA, USA). Measurements were 
taken by the same experienced examiner within a single visit. Data was 
acquired following the guidelines of the TFOS DEWS II Diagnostic 
Methodology Report, to avoid the destabilization of the tear film, in the 
following order [5]: Medical history, information regarding environ-
mental conditions and lifestyle, Ocular Surface Disease Index (OSDI), 
Dry Eye Questionnaire-5 (DEQ-5), Non-Invasive Keratograph Break-Up 
Time (NIKBUT), tear film osmolarity and ocular surface staining. The 
temperature and humidity of the room were maintained at 24.1 ± 1.6 ◦C 
and 44.9 ± 5.0 %, respectively. Measurements were performed between 
November 2018 and January 2019, minimizing seasonal variations. 
Participants were asked about their lifestyle, medical history, use of 
oral or topical medications, history of ophthalmic surgery and envi-
ronmental conditions. The risk factors included in the present study 
were those reported by the TFOS DEWS II Epidemiology Report [2,4,6]. 
Participants with rheumatoid arthritis, gout, osteoarthritis, fibromyalgia 
and osteoporosis were included under the classification of systemic 
rheumatologic disease, while bradycardia and heart failure were 
included under the classification of heart disease. Participants graded 
the quality of their diet as good (excellent or good quality) or poor (poor 
or fair quality). They were instructed to consider a good diet quality if 
they believe as having a balanced intake of protein, carbohydrates, fruits 
and vegetables; whilst a poor diet quality is an unbalanced diet, 
associated with the intake of ultra-processed food, ready-to-eat products 
and sugars. 
Table 1 shows the risk factors evaluated in the present study. No 
participant reported a history of Sjögren syndrome, rosacea, acne vul-
garis, psoriasis, lupus erythematosus, hepatitis C, steroids deficiency, 
chronic kidney disease or hematopoietic stem cell transplantation. 
Moreover, all participants used soft contact lenses daily; therefore, this 
variable was not included in the analysis since a binary logistic regres-
sion was not able to be performed. 
The first NIKBUT of the tear film was measured three consecutive 
times and the median was calculated. Measurements were taken every 3 
min to allow tear film stabilization between them [5,7]. Tear film 
osmometry was performed in both eyes using the TearLab Osmolarity 
device from 50 nL tear samples collected from the lower lateral canthus 
tear meniscus. The interocular difference in osmolarity was calculated 
[4,5]. 
Ocular surface staining was evaluated with fluorescein strips for the 
assessment of the cornea, and with lissamine strips for the assessment of 
the conjunctiva and eyelid margins using the TFOS DEWS II recom-
mended protocol [5]. The number of corneal and conjunctival spots was 
recorded [4,5,8]. Positive lid wiper epitheliopathy was defined as a lid 
margin staining ≥ 2 mm in length and/or ≥ 25 % of sagital width 
(excluding Marx’s line) [5,9]. 
The sample was classified following the indications of the TFOS 
DEWS II Diagnostic Methodology Report for the diagnosis of DED [5]. 
Participants were classified into the DED group if they had dry eye 
symptoms (OSDI ≥ 13 or DEQ-5 ≥ 6) and at least one altered homeo-
stasis marker (NIKBUT less than 10 s; osmolarity ≥ 308 mOsm/L; 
interocular osmolarity difference greater than 8 mOsm/L; corneal 
fluorescein staining greater than 5 spots; conjunctival lissamine green 
staining greater than 9 spots; or lid margin staining ≥ 2 mm length and 
≥ 25% width). 
2.2. Statistical analysis 
Statistical analysis was carried out using SPSS v26.0 for Windows 
(IBM Corp, Armonk, New York, USA). Results are presented as the mean 
± standard deviation (SD), as the median and interquartile range or as 
the number and percentage of participants, depending on the parameter. 
Normality distribution for each group was assessed via the 
Kolmogorov-Smirnov test or the Shapiro-Wilk test. Significant differ-
ences in age between healthy and DED groups were assessed using the 
Mann-Whitney U test, while sex differences between groups were eval-
uated using the Chi-square analysis. 
Univariate logistic regression was performed initially to identify the 
predictors of DED. Predictors with a p-value less than 0.15 were incor-
porated into the multivariate logistic regression analysis [4,6]. Collin-
earity assumption was checked among variables. A p-value of less than 
0.05 was considered statistically significant. 
The statistical power of the sample was calculated post-hoc using the 
G*Power 3.1 software [10]. A statistical power of 0.8 was achieved for 
logistic regression analysis with the sample size of 120 participants and a 
significance level of 0.05. 
3. Results 
One hundred and twenty right eyes from 120 participants were 
measured: 60 females (50 %) and 60 males (50 %). The mean ± SD age 
of the participants was 47.0 ± 22.8 years, ranging from 18 to 89 years. 
The comparison between the cohort of the sample and the Spanish 
population is shown in Fig. 1. 
No participant was previously diagnosed with DED. From the total 
sample, 44 participants (36.7 %) were classified into the healthy group 
(43.2 ± 21.2 years) and 76 (63.3 %) into the DED group (49.2 ± 23.5 
years) according to the criterion described in the TFOS DEWS II Diag-
nostic Methodology Report. Given that the cohort does not fully 
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represent the Spanish population (Fig. 1), a corrected prevalence was 
calculated by multiplying the DED rate found for each age group by the 
age proportion in each group. Results show a corrected prevalence of 
DED using the TFOS DEWS II criteria for the Mediterranean Caucasian 
population of 57.7 % with a confidence interval of 33.3–80.9 %. 
There were no statistically significant age differences between 
groups (Mann-Whitney U = 1886.5, p = 0.243). Sixty participants were 
females (50 %) and sixty males (50 %). Twenty-five per cent of females 
were classified into the healthy group and 75 % into the DED group, 
while 48 % of males were classified into the healthy group and 52 % into 
the DED group. The DED group had statistically higher number of fe-
males (X2 = 7.033, p = 0.008). Table 2 shows the demographic, clinical 
characteristics, and environmental and lifestyle factors of participants, 
while Table 3 shows the ocular surface parameters of the participants. 
Table 4 shows the univariate logistic regression and multivariate- 
adjusted logistic regression analysis, along with the odds ratios of DED 
for each factor. Given that the cohort does not fully represent the 
Spanish population, corrected odds ratios were calculated for each risk 
factor by multiplying the risk factor rate found for each age group by the 
age proportion in each group. The ratio between the corrected preva-
lence of that risk factor and the corrected odds ratio was obtained and 
multiplied for the odds ratio to obtain the corrected odds ratio. This 
procedure was repeated for each risk factor. In continuous variables, the 
median value was used to classify participants. 
Univariate logistic regression identified the following as potential 
risk factors for DED (p less than 0.15): Sex, sleep hours per day, meno-
pause, anxiety, systemic rheumatologic disease, use of anxiolytics, daily 
medication, ocular surgery, poor diet quality, percentage of ultra- 
processed food in diet, caffeine intake and hours of exposure to air 
conditioning per day. The interaction between DED and risk factors was 
statistically significant for sex, sleep hours per day, menopause, anxiety, 
systemic rheumatologic disease, use of anxiolytics and caffeine intake (p 
less than 0.05 for all). The multivariate logistic regression revealed that 
sleep hours per day, menopause and use of anxiolytics were indepen-
dently associated with DED (p ≤ 0.026 for all). 
4. Discussion 
The TFOS DEWS II Epidemiology Report noted that there is an 
extensive list of risk factors for DED because the tear film and ocular 
surface form part of a functional unit, which is influenced by lifestyle, 
environmental conditions, and systemic and ocular disease [2]. The 
authors acknowledged the need to study the principal and emerging risk 
factors of DED following the diagnostic guidelines reported in the TFOS 
DEWS II Diagnostic Methodology Report [2,5]. 
The TFOS DEWS II Epidemiology Report determined that ageing, 
feminine sex, Asian ethnicity, computer use, contact lens wear, inade-
quate environment, and use of antihistamines, antidepressants and an-
xiolytics were DED risk factors with consistent evidence. Nevertheless, 
these outcomes cannot be directly compared with the ones reported in 
the present study, as the TFOS DEWS II Report was constructed on the 
basis of previous cross-sectional investigations in which the disease 
diagnosis criterion and methodology differed considerably between 
studies. 
Consequently, the results of the present research can only be directly 
Table 1 





Hours of sleep per day 
Smoking 
Number of cigarettes smoked per day 
More than 5 cigarettes smoked per day 
Contact lens wear 
Hours per week of contact lens wear 
More than 56 h per week of contact lens wear 
Computer use 
Daily hours of computer use 
More than 4 h of daily computer use 
Exercise 
Not walking (sedentary lifestyle) 
Hours walking per day 
Not practising exercise 























Oral contraceptive therapy 
Anticoagulants 
Anxiolytics 
Blood glucose regulators 















Poor diet quality 
Non-omnivorous diet 
Non-oily fish diet 
Percentage of unprocessed food in diet 
Percentage of ultra-processed food in diet 
Drinking alcohol 
Units of alcohol per week 
More than 4 units of alcohol per week 
Not drinking caffeine 
Units of caffeine per day 
Litres of water per day 
Less than 2 L of water per day 
Environment 
Working 
Hours working per day  
Table 1 (continued ) 
Characteristic 
Working ≥ than 8 h per day 
Urban life 
Air conditioning 
Hours of exposure to air conditioning per day 
≥ 8 h of exposure to air conditioning per day 
Central heating 
Hours of exposure to central heating per day 
≥ 8 h of exposure to central heating per day  
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compared with the recent studies carried out by Wang et al. [4,6] on a 
New Zealand population. The present study adds the analysis of the 
interaction between systemic, environmental and lifestyle DED risk 
factors. The results of this study showed that DED was independently 
associated with the use of anxiolytics, menopause and sleep hours per 
day. 
4.1. Age and sex 
The association of DED with sex and ageing has been widely reported 
in previous studies. Several studies found an increase in DED prevalence 
with age [4,6,11–22], while some did not find a significant association 
[23–26]. Moreover, some reports indentified that feminine sex was 
related to DED [11–14,16,18–23,27], while others did not find a rela-
tionship [4,23,25,28]. 
In this study, no independent association was found between DED 
and age or sex. Even though chi-square analysis showed that the DED 
group had a statistically higher number of females and that the uni-
variate analysis identified that females were 1.6 times more likely to 
suffer from DED (p = 0.009), feminine sex was not found as statistically 
associated with DED in the multivariate analysis, which is in agreement 
with a previous study [24]. Also in consonance with the outcomes of this 
study, no independent association between sex and DED was found by 
Wang et al. [4]. Nevertheless, contrary to the Mediterranean Caucasian 
cohort results reported here, the authors did find an independent asso-
ciation between DED and age in their New Zealand cohort [4,6]. 
4.2. Medical conditions and medications 
Wang et al. [4] also reported an independent association with 
migraine headaches, systemic rheumatologic disease, thyroid disease 
and antidepressant medication. In the present work, participants who 
suffered from systemic rheumatologic disease had 2.8 times more risk to 
suffer from DED in the univariate regression (p = 0.047), but it was not 
statistically significant in the multivariate analysis. Other studies 
[13,19,29,30] have also confirmed the relationship between DED and 
systemic rheumatologic disease since this condition causes an increased 
concentration of inflammatory cytokines within the tear fluid and 
conjunctival epithelium, which causes an inflammatory infiltration and 
structural damage in the lacrimal glands [2,19,31,32]. 
Additionally, while there is inconclusive evidence as to whether 
menopause is a risk factor for DED [2], the present study found an in-
dependent association with DED. This could be because ovaries produce 
very low levels of estrogens and progesterone during menopause. It is 
thought that estrogens are responsible for the regulation of the synthesis 
of lipids in the meibomian glands, and both estrogens and progesterone 
modulate the inflammatory response. Researchers have also reported 
that the decrease in androgens during menopause is also associated with 
DED [33–36]. Contrary to the outcomes of the present study, Wang et al. 
[4] found that menopause was only statistically significant in the uni-
variate analysis, but was not statistically significant when its interaction 
with other variables was analysed. 
Several studies have found an association between DED and psy-
chological conditions such as anxiety, depression and stress 
[11,14–16,29,30,37,38]. However, there is no evidence whether these 
diseases are a cause or a consequence of DED. The TFOS DEWS II 
Epidemiology Report acknowledged the need for clarifying the role of 
anxiolytics and antidepressants in DED [2,11,38]. Different authors 
[11,13,15,17,38,39] found that anxiolytic medication was a risk factor 
for the development of dry eye. In support of this, the present study 
confirmed that anxiolytic medication was independently associated 
with DED. More precisely, participants who used anxiolytic medication 
were 5.7 times more likely to suffer from DED. Anxiety was identified as 
a potential predictor of DED (p = 0.016) in the univariate analysis, but 
was not independently associated with DED in the multivariate analysis. 
Therefore, the association between DED and anxiety could result as a 
consequence of the relationship between DED and anxiolytics. Besides, 
the use of daily medication was identified as a potential risk factor in the 
univariate analysis, but was not independently associated with DED in 
the multivariate analysis. Finally, no relationship was found with any 
other medical conditions. 
4.3. Lifestyle, exercise and environmental conditions 
Environmental factors such as air pollution, wind, low humidity, use 
of central heating or air conditioning have been suggested to impact the 
integrity of the ocular surface [2,24,40–42]. In the present study, air 
conditioning was identified as a potential risk factor for DED, but it did 
not show a statistically significant relationship with DED in the multi-
variate analysis. No other variable related to the environment showed a 
statistically significant association with DED. In contrast to the out-
comes of this study, Roh et al. [19] found that DED was more prevalent 
in those residing in urban areas and with indoor occupations. Practising 
regular exercise showed no association with DED either, in agreement 
with previous studies [6,15,30,37]; although Sano et al. [43] found that 
physical exercise decreased dry eye symptoms in healthy office workers, 
which might suggest that exercise has an optimal impact on ocular 
surface health. 
Regarding sleep hours per day, Murube et al. [44] hypothesized that 
rapid eye movement during sleep serves to increase tear secretion and to 
humidify and lubricate the ocular surface. The present study confirms 
that participants sleeping less hours are more likely to suffer from DED. 
Specifically, each additional sleeping hour reduced the probability of 
suffering DED by 0.8 times. Conversely, Wang et al. [6] and Na et al. 
[30] did not find any association between DED and hours of sleep. 
It has been also reported that DED is more prevalent in contact lens 
Fig. 1. Tornado plots representing the sample cohort (left) and the Spanish population (right).  
J.V. García-Marqués et al.                                                                                                                                                                                                                    
Contact Lens and Anterior Eye xxx (xxxx) xxx
5
wearers [2,3,13,23,27,45,46]; nevertheless, the present study did not 
reveal an association, in agreement with other generally more recent 
studies [4,12,18]. Wang et al. [4,6], who used the same diagnostic cri-
terion as the present study, did not find an independent association 
between contact lens wear and DED either, perhaps due to advances in 
Table 2 
Demographic, clinical, environmental and lifestyle characteristics of 
participants.  
Characteristic Results 
Age (mean ± SD) 47.0 ± 22.8 
years 
Female sex (number of participants, percentage of participants) 60, 50 % 
Lifestyle 
Hours of sleep per day (mean ± SD) 7.1 ± 1.2 
Smoking (number of participants, percentage of participants) 31, 26 % 
Number of cigarettes smoked per day (mean ± SD) 2.6 ± 6.2 
More than 5 cigarettes smoked per day (number of participants, 
percentage of participants) 
19, 16 % 
Contact lens wear (number of participants, percentage of participants) 37, 31 % 
Hours per week of contact lens wear (mean ± SD) 15.6 ± 29.3 
More than 56 h per week of contact lens wear (number of 
participants, percentage of participants) 
16, 13 % 
Computer use (number of participants, percentage of participants) 71, 59 % 
Daily hours of computer use (mean ± SD) 2.9 ± 3.1 
More than 4 h of daily computer use (number of participants, 
percentage of participants) 
37, 31 % 
Exercise 
Not walk (sedentary lifestyle) (number of participants, percentage of 
participants) 
29, 24 % 
Hours walking per day (mean ± SD) 1.1 ± 1.1 h 
Not practise exercise (number of participants, percentage of 
participants) 
77, 64 % 
Hours practising exercise per week (mean ± SD) 2.2 ± 4.7 h 
Medical conditions 
Menopause (number of participants, percentage of participants) 21, 18 % 
Allergic rhinitis (number of participants, percentage of participants) 19, 16 % 
Asthma (number of participants, percentage of participants) 7, 6 % 
Hypertension (number of participants, percentage of participants) 21, 18 % 
Ovarian dysfunction (number of participants, percentage of 
participants) 
5, 4 % 
Anxiety (number of participants, percentage of participants) 18, 15 % 
Systemic rheumatologic disease (number of participants, percentage 
of participants) 
16, 13 % 
Diabetes (number of participants, percentage of participants) 12, 10 % 
Hypercholesterolemia (number of participants, percentage of 
participants) 
11, 9 % 
Glaucoma (number of participants, percentage of participants) 6, 5 % 
Migraine headaches (number of participants, percentage of 
participants) 
8, 7 % 
Depression (number of participants, percentage of participants) 8, 7 % 
Heart disease (number of participants, percentage of participants) 2, 2 % 
Thyroid disease (number of participants, percentage of participants) 5, 4 % 
Schizophrenia (number of participants, percentage of participants) 2, 2 % 
Eczema (number of participants, percentage of participants) 4, 3 % 
Stress (number of participants, percentage of participants) 10, 8 % 
Medications 
Antihistamines (number of participants, percentage of participants) 9, 8 % 
Antihypertensives (number of participants, percentage of participants) 20, 17 % 
Stomach protector (number of participants, percentage of participants) 4, 3 % 
Oral contraceptive therapy (number of participants, percentage of 
participants) 
7, 6 % 
Anticoagulants (number of participants, percentage of participants) 7, 6 % 
Anxiolytics (number of participants, percentage of participants) 21, 18 % 
Blood glucose regulators (number of participants, percentage of 
participants) 
9, 8 % 
Topical anti-glaucoma medication (number of participants, 
percentage of participants) 
6, 5 % 
Antidepressants (number of participants, percentage of participants) 4, 3 % 
Hypercholesterolemia medication (number of participants, 
percentage of participants) 
7, 6 % 
Anti-inflammatories (number of participants, percentage of 
participants) 
3, 3 % 
Medication for thyroids (number of participants, percentage of 
participants) 
3, 3 % 
Antipsychotics (number of participants, percentage of participants) 2, 2 % 
Daily medication (number of participants, percentage of participants) 58, 48 % 
Ocular surgery 
Ocular surgery (number of participants, percentage of participants) 25, 21 % 
Retinal surgery (number of participants, percentage of participants) 2, 2 % 
Refractive surgery (number of participants, percentage of participants) 5, 4 % 
Pterygium surgery (number of participants, percentage of participants) 1, 1 % 
Glaucoma surgery (number of participants, percentage of participants) 2, 2 %  
Table 2 (continued ) 
Characteristic Results 
Cataract surgery (number of participants, percentage of participants) 16, 13 % 
Diet 
Poor diet quality (number of participants, percentage of participants) 19, 16 % 
Non-omnivorous diet (number of participants, percentage of 
participants) 
11, 9 % 
Non-oily fish diet (number of participants, percentage of participants) 79, 66 % 
Percentage of unprocessed food in diet (mean ± SD) 65 ± 20 % 
Percentage of ultra-processed food in diet (mean ± SD) 8 ± 11 % 
Drinking alcohol (number of participants, percentage of participants) 83, 67 % 
Units of alcohol per week (mean ± SD) 3.2 ± 5.0 
units 
More than 4 units of alcohol per week (number of participants, 
percentage of participants) 
30, 25 % 
Not drinking caffeine (number of participants, percentage of 
participants) 
28, 23 % 
Units of caffeine per day (mean ± SD) 1.5 ± 1.5 
units 
Litres of water per day (mean ± SD) 1.7 ± 0.8 L 
Less than 2 L of water per day (number of participants, percentage of 
participants) 
73, 61 % 
Environment 
Working (number of participants, percentage of participants) 57, 48 % 
Hours working per day (mean ± SD) 3.7 ± 4.1 h 
Working ≥ than 8 h per day (number of participants, percentage of 
participants) 
42, 35 % 
Urban life (number of participants, percentage of participants) 49, 41 % 
Air conditioning (number of participants, percentage of participants) 90, 75 % 
Hours of exposure to air conditioning per day (mean ± SD) 4.2 ± 4.1 h 
≥ 8 h of exposure to air conditioning per day (number of participants, 
percentage of participants) 
31, 26 % 
Central heating (number of participants, percentage of participants) 91, 76 % 
Hours of exposure to central heating per day (mean ± SD, years) 4.7 ± 4.7 h 
≥ 8 h of exposure to central heating per day (number of participants, 
percentage of participants) 
34, 28 % 
Where: SD = Standard Deviation. 
Table 3 
Ocular surface parameters of participants.  
Characteristic Total Healthy group DED group 
OSDI score (median, IQR) 16.7, 6.3–30.3 4.2, 0–8.3 22.6, 
13.9–42.7 
DEQ-5 score (median, 
IQR) 
7, 4–12 3, 1–5 10, 7–14 
NIKBUT (median, IQR) 6.69, 4.40–10.66 
s 











312.0–331.0 mOsmol/L    
Difference in osmolarity 




9, 4.5–11.5 13, 4–22 
Corneal staining greater 
than 5 spots (number of 
participants) 
12 2 10 
Corneal staining greater 
than 9 spots (number of 
participants) 
16 3 13 
Lid margin staining ≥ 2 
mm of length and ≥ 25 
% of width (number of 
participants) 
31 5 26 
Where: IQR = Interquartile range, DED = Dry Eye Disease, DEQ = Dry Eye 
Questionnaire, mOsmol/L = Milliosmoles per liter, NIKBUT = Non-Invasive 
Keratograph Break-Up Time and OSDI = Ocular Surface Disease Index. 
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Table 4 
Univariate and multivariate logistic regressions and odds ratios of dry eye disease for demographic and clinical characteristics.  


















Age 1.012/1.522 0.995/1.516 1.029/1.568  0.164 – – –  – 
Age (per 10 years) 1.125/1.714 0.945/1.440 1.338/2.039  0.185 – – –  – 
Female sex 2.806/1.603 1.295/0.740 6.081/3.473  0.009* – – –  – 
Lifestyle         
Hours of sleep per day 0.654/0.792 0.469/0.568 0.911/1.103  0.012* 0.588/0.712 0.388/0.470 0.891/1.079  0.012* 
Smoking 1.298/2.200 0.546/0.926 3.086/5.231  0.555 – – –  – 
Number of cigarettes smoked per 
day 
1.030/1.746 0.961/1.629 1.104/1.872  0.406 – – –  – 
More than 5 cigarettes smoked per 
day 
1.307/1.861 0.458/0.652 3.726/5.304  0.617 – – –  – 
Contact lens wear 0.788/0.770 0.355/0.348 1.747/1.712  0.557 – – –  – 
Hours per week of contact lens 
wear 
1.001/0.981 0.988/0.968 1.015/0.995  0.825 – – –  – 
More than 56 h per week of contact 
lens wear 
0.897/0.879 0.301/0.295 2.676/2.622  0.846 – – –  – 
Computer use 0.745/0.874 0.347/0.418 1.598/1.927  0.449 – – –  – 
Daily hours of computer use 0.961/1.159 0.852/1.027 1.084/1.307  0.522 – – –  – 
More than 4 h of daily computer 
use 
0.567/0.766 0.257/0.347 1.254/1.694  0.161 – – –  – 
Exercise         
Not walk (sedentary lifestyle) 0.636/0.713 0.272/0.305 1.489/1.670  0.297 – – –  – 
Hours walking per day 1.081/1.146 0.771/0.817 1.514/1.605  0.652 – – –  – 
Not practise exercise 1.412/1.734 0.655/0.804 3.045/3.740  0.378 – – –  – 
Hours practising exercise per week 0.827/0.929 0.580/0.651 1.179/1.324  0.293 – – –  – 
Medical conditions         
Menopause 7.000/3.458 1.546/0.794 31.705/ 
15.662  
0.012* 8.759/4.327 1.571/0.776 48.835/2.124  0.013* 
Allergic rhinitis 1.307/2.186 0.458/0.766 3.726/6.232  0.617 – – –  – 
Asthma 1.479/1.039 0.275/0.193 7.964/5.593  0.649 – – –  – 
Hypertension 2.080/1.502 0.705/0.509 6.138/4.432  0.185 – – –  – 
Ovarian dysfunction 1001139339/        
624410605.7 0.000 – 0.999  – – – –  
Anxiety 12.390/14.313 1.587/1.833 96.698/ 
111.706  
0.016* – – –  – 
Systemic rheumatologic disease 4.742/2.817 1.024/0.608 21.954/ 
13.041  
0.047* – – –  – 
Diabetes 0.791/0.908 0.235/0.270 2.661/3.054  0.705 – – –  – 
Hypercholesterolemia 1.608/1.765 0.404/0.444 6.406/1.033  0.501 – – –  – 
Glaucoma 3.028/1.329 0.342/0.150 26.793/ 
11.755  
0.319 – – –  – 
Migraine headaches 4.362/3.358 0.519/0.340 36.694/ 
28.251  
0.175 – – –  – 
Depression 4.362/1.882 0.519/0.224 36.694/ 
15.833  
0.175 – – –  – 
Heart disease 0.573/1.672 0.035/0.102 9.400/27.424  0.697 – – –  – 
Thyroid disease 0.863/0.346 0.139/0.056 5.375/2.153  0.875 – – –  – 
Schizophrenia 0.573/0.378 0.035/0.023 9.400/6.204  0.697 – – –  – 
Eczema 0.566/1.373 0.057/0.138 5.612/13.610  0.627 – – –  – 
Stress 2.471/4.308 0.501/0.874 12.194/ 
21.261  
0.267 – – –  – 
Medications         
Antihistamines 1.171/2.784 0.278/0.661 4.937/11.736  0.829 – – –  – 
Antihypertensives 1.918/1.404 0.646/0.473 5.699/4.171  0.241 – – –  – 
Stomach protector 1.767/1.150 0.178/0.116 17.526/ 
11.404  
0.627 – – –  – 
Oral contraceptive therapy 3.686/2.027 0.429/0.236 31.666/ 
17.410  
0.235 – – –  – 
Anticoagulants 0.759/1.275 0.162/0.272 3.560/5.979  0.727 – – –  – 
Anxiolytics 15.357/7.901 1.982/1.020 118.972/ 
61.211  
0.009* 11.072/5.697 1.338/0.688 91.611/ 
47.134  
0.026* 
Blood glucose regulators 2.130/2.806 0.423/0.557 10.740/ 
14.150  
0.359 – – –  – 
Topical anti-glaucoma medication 3.028/1.607 0.342/0.182 26.793/ 
14.222  
0.319 – – –  – 
Antidepressants 1.767/1.149 0.178/0.116 17.526/ 
11.397  
0.627 – – –  – 
Hypercholesterolemia medication 3.686/4.791 0.429/0.558 31.666/ 
41.163  
0.235 – – –  – 
Anti-inflammatories 0.280/0.169 0.025/0.015 3.180/1.921  0.305 – – –  – 
Medication for thyroids 0.280/0.117 0.025/0.010 3.180/1.328  0.305 – – –  – 
Antipsychotics 0.573/0.378 0.035/0.023 9.400/6.204  0.697 – – –  – 
(continued on next page) 
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contact lens materials and greater use of daily disposables [47]. 
Furthermore, some studies have shown that DED is more prevalent in 
workers using visual displays as a consequence of a reduced blink fre-
quency and an increase in incomplete blinking during visual display 
visualization, which have both shown to increase tear evaporation 
[3,12,27,46]. Wang et al. [6] found that increased hours of digital screen 
exposure per day was independently associated with DED. Nevertheless, 
in agreement with other reports [17,24,39], the present study did not 
reveal an association between DED and digital display use. 
It has also been suggested that cigarette smoking is a risk factor for 
DED [2,30,48–50]. Some studies state that not only is smoking a risk 
factor by itself, but environmental exposure to smoke can develop dry 
eye symptoms [48,50]. Nevertheless, other authors did not find a sig-
nificant association with DED and the TFOS DEWS II Epidemiology 
Report concluded that it is inconclusive whether smoking is a risk factor 
for DED [2,12,14,15,17,23,27,39,46]. In this regard, in agreement with 
the study of Wang et al. [6], the results of this study did not reveal an 
association between DED and smoking. 
4.4. Diet 
Diet quality has been also reported as possibly associated with DED. 
Conditions such as vitamin A or D deficiency, eating disorders or a vegan 
diet might be related to DED [2,3,51,52]. In the present study, poor diet 
quality approached the statistical significance cut-off in the multivariate 
analysis (p = 0.050). The percentage of ultra-processed food was 
included in the multivariate analysis since it was found to be a potential 
predictor of DED in the univariate analysis (p = 0.084). However, it did 
not reveal an independent association with DED. Essential fatty acids 
play a relevant role in the tear film and ocular surface healthiness since 
they enhance the tear film lipid layer and reduce the expression of some 
inflammatory markers [2,3,53]. This role is still not fully understood, 
however [2]. The present study did not find an association between DED 
and non-oily fish or non-omnivorous diet. 
Regarding alcohol consumption, the TFOS DEWS II Epidemiology 
Report considered the evidence as inconclusive as to whether it was a 
risk factor for DED [2,15]. In agreement with the study of Wang et al. 
[6], the present study did not find an association between alcohol con-
sumption and DED. 
Some studies [2,14,17] have reported that drinking caffeine in-
creases tear production; in the present study this factor did not reveal an 
independent association with DED, although the univariate analysis 
showed that participants who did not drink caffeine had 1.7 times more 
probability to suffer from DED (p = 0.023). In the study of Wang et al. 
Table 4 (continued ) 


















Daily medication 1.861/2.037 0.873/0.956 3.963/4.338  0.108 – – –  – 
Ocular surgery         
Ocular Surgery 2.111/1.941 0.772/0.710 5.770/5.304  0.145 – – –  – 
Retinal surgery 960552609.3/        
2,802,316,182 0.000 – 0.999  – – – –  
Refractive surgery 2.389/2.070 0.259/0.224 22.075/ 
19.128  
0.443 – – –  – 
Pterygium surgery 0.000 0.000 –  1.000 – – –  – 
Glaucoma surgery 960552609.3/        
421442457.3 0.000 – 0.999  – – – –  
Cataract surgery 1.875/1.524 0.566/0.460 6.216/5.054  0.304 – – –  – 
Diet         
Poor diet quality 3.644/3.430 0.998/0.939 13.312/ 
12.532  
0.050 3.853/3.627 0.978/0.921 15.168/ 
14.279  
0.054 
Non-omnivorous diet 1.608/1.338 0.404/0.336 6.406/5.329  0.501 – – –  – 
Non-oily fish diet 1.166/1.558 0.535/0.715 2.539/3.393  0.700 – – –  – 
Percentage of unprocessed food in 
diet 
0.985/0.615 0.966/0.603 1.006/0.628  0.154 – – –  – 
Percentage of ultra-processed 
food in diet 
1.046/1.590 0.994/1.511 1.102/1.675  0.084 – – –  – 
Drinking alcohol 1.055/1.328 0.481/0.605 2.315/2.914  0.893 – – –  – 
Units of alcohol per week 1.026/1.210 0.948/1.118 1.111/1.310  0.529 – – –  – 
More than 4 units of alcohol per 
week 
1.214/1.432 0.508/0.599 2.900/3.420  0.662 – – –  – 
Not drinking caffeine 3.385/1.703 1.182/0.595 9.690/4.876  0.023* – – –  – 
Units of caffeine per day 0.892/0.449 0.695/0.350 1.145/0.576  0.369 – – –  – 
Litres of water per day 0.985/1.116 0.921/1.043 1.053/1.193  0.663 – – –  – 
Less than 2 L of water per day 1.122/1.271 0.526/0.596 2.396/2.714  0.766 – – –  – 
Environment         
Working 0.739/0.653 0.351/0.310 1.556/1.375  0.426 – – –  – 
Hours working per day 0.968/0.855 0.885/0.782 1.059/0.936  0.483 – – –  – 
Working ≥ than 8 h per day 0.910/0.800 0.419/0.3685 1.977/1.739  0.812 – – –  – 
Urban life 1.565/1.562 0.725/0.723 3.380/3.373  0.254 – – –  – 
Air conditioning 1.455/1.682 0.626/0.724 3.381/3.908  0.383 – – –  – 
Hours of exposure to air 
conditioning per day 
1.085/1.094 0.981/0.989 1.201/1.211  0.112 – – –  – 
≥ 8 h of exposure to air 
conditioning per day 
1.584/1.597 0.654/0.659 3.837/3.867  0.308 – – –  – 
Central heating 1.074/1.189 0.453/0.502 2.547/2.820  0.871 – – –  – 
Hours of exposure to central 
heating per day 
0.973/1.077 0.900/0.996 1.051/1.164  0.483 – – –  – 
≥ 8 h of exposure to central 
heating per day 
1.302/1.667 0.562/0.720 3.015/3.861  0.538 – – –  – 
Where: CI = 95 % Confidence Interval. * = Statistically significant values. Bold = Variables included in the multivariate analysis (p < 0.15). 
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[6] reduced caffeine intake per day was indentified as a risk factor for 
DED. 
4.5. Ocular surgery 
Ocular surgery, such as refractive or cataract surgery, have been 
identified as potential risk factors for DED [2,14,18,20,39,45,54,55]. 
Ocular surgery was included in the multivariate analysis since it was 
found to be a potential predictor of DED in the univariate analysis (p =
0.145), but it did not reveal an independent association with DED. 
The present study has some limitations that must be taken into ac-
count. First, dry eye classification subtypes (aqueous deficient and 
evaporative) were not considered in the analysis. Thus, both types of 
DED were analysed altogether. Medical history, environmental and 
lifestyle factors were self-reported by participants, which might have 
induced recall bias, although this can be considered as an inherent 
limitation of any cross-sectional study. 
The magnitude of the prevalence of DED was higher than in previous 
studies of similar nature. Thus, the presented prevalence was corrected 
for the general population and was still notably higher than that re-
ported in New Zealand using the same diagnostic criteria [4,6]. The new 
DED diagnostic criterion, described in the TFOS DEWS II, is less 
restrictive and has been reported to increase the prevalence of the dis-
ease [4]. Heat and humidity of the region could also have increased the 
prevalence in a Mediterranean Caucasian population. Previous research 
[56] found that dry eye was more prevalent in Spain than in another 
country with different levels of environmental humidity. Moreover, a 
recent study [57] informed that the number of patients with DED has 
increased steadily throughout the years in Spain, which might be 
partially caused by modern-day workplace in Spanish society. In addi-
tion, the high prevalence found in the present study might be in 
agreement with the high incidence of clinical tests, sale of dry eye 
products and the number of dry eye specialist visits reported in Spain 
[17,58–61]. Although all these points might explain the high prevalence 
of DED in the results, the recruitment process through an open adver-
tisement could also have induced a higher prevalence of DED than ex-
pected in the general population.Some of these limitations are also 
acknowledged to exist in previous studies with similar designs [2,4]. 
Moreover, although participants were assessed in a single visit and in 
the same laboratory under controlled environmental conditions, sea-
sonal variations may have induced some variability in the results. 
Nevertheless, such variations can be considered minimal since mea-
surements were performed between November 2018 and January 2019. 
As in a previous study [4], the wide confidence intervals found, might 
have decreased the study power, and the high number of variables 
included might have induced false-positive results. Nonetheless, this 
issue was partially minimized by the fact that not all these variables 
were analysed together: although 76 variables were assessed as risk 
factors in the univariate analysis, only 12 of them were finally analysed 
together and included in the multivariate logistic regression. 
In addition, the cohort of the present study is not completely 
representative of the Spanish population since there is a gap in the ’50 s 
and ’60 s. To amend this issue, a corrected prevalence for the Spanish 
population and a corrected risk factor odds ratio were calculated. 
Likewise, the chances of finding a significant value are low in the factors 
that are not common in the cohort. Therefore, factors that have a low 
percentage of people in the sample cannot be excluded as risk factor for 
DED. Finally, the main limitation of this work was the number of par-
ticipants recruited, which could explain the lack of association with 
factors such as age or sex, although the sample analysis showed that such 
sample size was able to provide a good level of statistical power. In any 
case, the results of the present study allow a hypothesis to be built for 
testing in future studies. 
Overall, the present study found that DED following the diagnostic 
guidelines of the TFOS DEWS II Diagnostic Methodology Report had a 
prevalence of 57.7 % in a Mediterranean Caucasian population. DED is 
independently associated with anxiolytic medication, less sleep hours 
per day and menopause. This work identifies the key risk factors of DED 
to be used in the screening of the condition. Clinicians should 
acknowledge the importance of triaging questions, systemic comorbid-
ities and risk factors when managing a patient with dry eye symptoms. 
Moreover, the present study identifies potentially modifiable risk fac-
tors, in addition to conventional treatments for DED. Finally, clinicians 
should be aware that not only ocular surface assessment, but also sys-
temic and environmental examination are relevant for DED participants. 
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